CD40LG and Ito hypomelanosis: A multicentre prospective study evaluated the clinical performance of a commercial specific IgM antibody against A. fumigatus for the first time, and the results revealed that the detection of serum IgM antibody specific to A.fumigatus is of little help in the current diagnosis of IPA and CPA in Chinese patients, which is consistent with our results [28, 29].